Loading ...

Blob

Smart Reasoning:

C&E

See more*

Qaagi - Book of Why

Causes

Effects

combination of mutation in RPN12 ( a lid component gene ) with mutations in RPT1 ( an ATPase genecausessynthetic lethality

the two mutationsresultedin synthetic lethality

a single mutation(passive) was caused bythe synthetic lethality

Only priC mutationscreatedsynthetic lethality

genomic mutationscausesynthetic lethality

Mutations in the RVS genesleadto synthetic lethality

the combination of mutations in the three genescausessynthetic lethality

The combination of the two viable mutations carnation and lightleadsto synthetic lethality

Mutation of conserved residuescausedsynthetic lethality

a single locus mutation(passive) was caused bythe synthetic lethality

mutation at a single locus(passive) was ... caused bythe synthetic lethality

combining a BRCA1/2 mutation and PARP inhibitioncreatessynthetic lethality

recessive lethal mutationsleadingto synthetic lethality

ste20Δ and ste7Δ mutationscausedsynthetic lethality

that genes whose mutations togetherresultin synthetic lethality

a specific interaction between PARP inhibition and BRCA1/2 mutationcan leadto synthetic lethality

mutation of any of the other factors leads to further destabilizationresultingin synthetic lethality

the additional mutation of ScSgs1 / AtRECQ4Aleadsto synthetic lethality

in women with BRCA1/2 mutationleadsto synthetic lethality

p53 mutation and Wee1 inhibition(passive) caused bythe synthetic lethality

thesld and dpb11 - 1 mutations(passive) caused bythe synthetic lethality

21 petite negative mutationsresultin synthetic lethality

20].A combination of this secY mutation and the secG deletionresultedin synthetic lethality

mutations in two genes functioning in two interacting pathways(passive) caused bysynthetic lethality

1.Loss of RKR1 and RTF1leadsto synthetic lethality

simultaneous PARP inhibition and HR deficiencycausessynthetic lethality [ 49,50

PARP inhibition in the presence of BRCA deficiencyleadsto synthetic lethality

combined Δtig::kan and ΔdnaK mutationscausesynthetic lethality

F ) Mutation of SLX1 , SLX4 , MUS81 , and MMS4causessynthetic lethality

disruption of base pairing and not an additional effect of the mutations(passive) was caused bythe synthetic lethality

however , BRCA1/2 mutations compromise HRRresultingin synthetic lethality

either mcs6ts2 or pmh1 - 26 mutations with sep10Δcausedsynthetic lethality

Mitachi T , Targeting p300 addiction in CBP - deficient cancerscausessynthetic lethality

Plasmid combinations indicated with the ' - ' symbolresultedin synthetic lethality

the co‐ablation of kri‐1 ( CCM1 ) and ccm‐3 in C. elegans(passive) caused bythe synthetic lethality

PARP1 inhibitors [ 21(passive) triggered bysynthetic lethality

The presence of a BRCA gene mutation , plus a PARP inhibitorcreatessynthetic lethality

PARP inhibitors in HR - deficient cells(passive) caused bySynthetic lethality

Similar to the loss of ATM , hypomorphic mutations of Mre11 ( Mre11ATLD1ledto synthetic lethality

and rodZ genescausedsynthetic lethality

novel therapeutic approaches to cancer | Molecular Cancer Therapeutics Abstract B24to designnovel therapeutic approaches to cancer | Molecular Cancer Therapeutics Abstract B24

from BEZ235 inhibition of ATR leading to replicative stress in TP53 deficient cellsresultingfrom BEZ235 inhibition of ATR leading to replicative stress in TP53 deficient cells

by combining Olaparib with BRCA2-Rad51 disruptors Falchi , Federico , et al 2017 ACS Chemical Biologytriggeredby combining Olaparib with BRCA2-Rad51 disruptors Falchi , Federico , et al 2017 ACS Chemical Biology

to cell death due to a synergistic effect in an already DDR - deficient background , such as PARP inhibitionleadsto cell death due to a synergistic effect in an already DDR - deficient background , such as PARP inhibition

from specific allele combinationsresultfrom specific allele combinations

by in silico removal of slc14a1 and slc14a2 genescausedby in silico removal of slc14a1 and slc14a2 genes

from an imbalance in the stoichiometry of ETC complexesresultingfrom an imbalance in the stoichiometry of ETC complexes

from inefficient or failed kinetochore assembly and consequent catastrophic increases in chromosome losswould resultfrom inefficient or failed kinetochore assembly and consequent catastrophic increases in chromosome loss

from the loss of both Mus81-Mms4 and Sgs1-Top3resultingfrom the loss of both Mus81-Mms4 and Sgs1-Top3

from multiple mutations in the sterol biosynthetic pathwayresultingfrom multiple mutations in the sterol biosynthetic pathway

in a lethal phenotypeto resultin a lethal phenotype

in part by poor complementation of the sterol intermediates with wild - type sphingolipids , suppression of lethality by mutating YND1 or GDA1is causedin part by poor complementation of the sterol intermediates with wild - type sphingolipids , suppression of lethality by mutating YND1 or GDA1

from such a drastic perturbation of SecY complex structure that suppressors would cause a significant but compensatory alterationcould resultfrom such a drastic perturbation of SecY complex structure that suppressors would cause a significant but compensatory alteration

to our understanding of SecYE structurehad contributedto our understanding of SecYE structure

from the failure to express the essential gene(swould resultfrom the failure to express the essential gene(s

from an inability to repair SSBs by either PARP1-dependent SSB repair or BRCA1/2-dependent HRRresultingfrom an inability to repair SSBs by either PARP1-dependent SSB repair or BRCA1/2-dependent HRR

from simultaneous deletion of PRS1 and PRS5 or PRS3 and PRS5 [ 7,9resultingfrom simultaneous deletion of PRS1 and PRS5 or PRS3 and PRS5 [ 7,9

from the combination of two temperature - sensitive mutations affecting the same essential process , such as DNA replicationresultsfrom the combination of two temperature - sensitive mutations affecting the same essential process , such as DNA replication

from the overexpression of Nop17l[Scer\UAS.Tresultingfrom the overexpression of Nop17l[Scer\UAS.T

from loss of SETD2 and WEE1resultingfrom loss of SETD2 and WEE1

from the combination of the ΔltaS mutation with the ΔtagO mutation , which eliminates WTA ... suggesting that LTA and WTA have complementing essential functionsresultsfrom the combination of the ΔltaS mutation with the ΔtagO mutation , which eliminates WTA ... suggesting that LTA and WTA have complementing essential functions

from an accumulation of DNA lesions in the double mutant cells that might be detectable as genome instability in the viable double mutants , pol3 - 5DE or -5DV with rad27-pcould resultfrom an accumulation of DNA lesions in the double mutant cells that might be detectable as genome instability in the viable double mutants , pol3 - 5DE or -5DV with rad27-p

from combination of a tsa1Δ mutation with defects in postreplication repair or recombinationresultingfrom combination of a tsa1Δ mutation with defects in postreplication repair or recombination

from inhibition of DNA replicationresultedfrom inhibition of DNA replication

from the concomitant inhibition of two independent pathways that are nonessential per seresultingfrom the concomitant inhibition of two independent pathways that are nonessential per se

cell viability that can point to potential cancer treatment targets ( McLornan et al .preventscell viability that can point to potential cancer treatment targets ( McLornan et al .

from the combined effects of tubulin misfolding and defects in microtubule assembly caused by the stu1 - 5 mutationmay resultfrom the combined effects of tubulin misfolding and defects in microtubule assembly caused by the stu1 - 5 mutation

from the driverresultingfrom the driver

DNA damage or prevent DNA repaircauseDNA damage or prevent DNA repair

from PARP1 inhibition and BRCA1 or BRCA2 lossresultingfrom PARP1 inhibition and BRCA1 or BRCA2 loss

in profound tumor cell cytotoxicityresultingin profound tumor cell cytotoxicity

from ELP3 and H4 tail mutationresultingfrom ELP3 and H4 tail mutation

to phase - specific cytotoxic drugscould be createdto phase - specific cytotoxic drugs

in the disintegration of the tumor cell ( Figure 1resultingin the disintegration of the tumor cell ( Figure 1

in its ability to promote cytotoxicity and death of refractory cancers that have mutations in tumor suppressor functionsresultsin its ability to promote cytotoxicity and death of refractory cancers that have mutations in tumor suppressor functions

when mutant KRAS and mutant EGFR are co - expressed in human lung adenocarcinoma ( LUAD ) cells ... revealing the biological basis for the mutual exclusivity of KRAS and EGFR mutations in lung cancersresultswhen mutant KRAS and mutant EGFR are co - expressed in human lung adenocarcinoma ( LUAD ) cells ... revealing the biological basis for the mutual exclusivity of KRAS and EGFR mutations in lung cancers

to functional HRR - mediated DNA repairleadsto functional HRR - mediated DNA repair

from deletion of both regulatory genesresultingfrom deletion of both regulatory genes

from a genomic rather than a plasmid - borne mutationresultedfrom a genomic rather than a plasmid - borne mutation

when mutant KRAS and mutant EGFR are coexpressed in human lung adenocarcinoma ( LUAD ) cells , revealing the biological basis for the mutual exclusivity of KRAS and EGFR mutations in lung cancersresultswhen mutant KRAS and mutant EGFR are coexpressed in human lung adenocarcinoma ( LUAD ) cells , revealing the biological basis for the mutual exclusivity of KRAS and EGFR mutations in lung cancers

Blob

Smart Reasoning:

C&E

See more*